GroPep launches new Assay kit for cancer research
Listed biopharmaceutical company GroPep Limited (ASX: GRO) todayannounced the release of a novel Assay kit to be used in the detectionof a range of diseases, including cancer.
Insulin
Very obese fare worse after colon cancer diagnosis
Obese patients are more likely to have a recurrence of colon cancer than their normal-weight counterparts and face an increased risk of dying from the disease, while it’s not clear that losing weight would improve their prognosis.
Diabetes :: Joslin?s Latino Diabetes Initiative Launches Its First Audio-Novella
Rosa?s Story, an audio-novella from the Joslin Diabetes Center Latino Diabetes Initiative, uses the art of storytelling to educate listeners about the challenges of diabetes faced by the Hispanic/Latino population. The first-person accounts of a fictitious Latino woman with type 2 diabetes, and a teenager with pre-diabetes, are told in the new educational package. Designed for Spanish-speaking Latinos with diabetes and their families, the three-CD set is being launched on Nov. 14, World Diabetes Day, a day set aside by the International Diabetes Federation (IDF) and the World Health Organization to increase public awareness of the global diabetes epidemic.
Diabetes :: Diabetes drug may reduce cardiovascular risks
A drug commonly used to increase the body’s sensitivity to insulin may slow the progression of cardiovascular disease in patients with type 2 diabetes, according to a study at the University of Illinois at Chicago College of Medicine.
Diabetes :: Diabetes medicine pioglitazone helps slow progression of artery wall thickening
A medication given to diabetics to improve their body’s sensitivity to insulin also appears to slow the thickening of their artery walls, according to a study posted online today by JAMA. The study is being released early to coincide with its presentation at the American Heart Association Scientific Session. It will be published in the December 6 print issue of JAMA.
New Micropump Should Aid Development of Lab-on-a-Chip
Using material similar to bathtub caulk, University of Utah engineers invented a tiny, inexpensive ?micropump? that could be used to move chemicals, blood or other samples through a card-sized medical laboratory known as a lab-on-a-chip.
Diabetes :: Stem Cells can cure diabetes
Researchers from the New Orleans’ Tulane University reveal that stem cells can cure diabetes. Researchers have used stem cells from human bone marrow to successfully treat diabetic mice.
Health :: Abbott to Expand Presence in Lipid Management Market with Acquisition of Kos Pharmaceuticals
Abbott and Kos Pharmaceuticals, Inc. today announced a definitive agreement for Abbott to acquire Kos for $78 per share in cash, for a total transaction value of $3.7 billion, net of cash currently held by Kos. Based in Cranbury, N.J., Kos is a specialty pharmaceutical company that develops and markets proprietary medications for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company has a growing presence in the $20 billion lipid management market.
Low Carb Diet :: Low carb diets and risk of heart disease – new research
Low-carbohydrate diets have been advocated for weight loss and to prevent obesity, but the long-term safety of these diets has not been determined. A study was conducted by Dr. Hu at the Department of Nutrition, Harvard School of Public Health, Boston.
Cancer :: Growth factor signals influence balance between normal growth and cancerous growth – USA
Too much of a signaling protein called insulin-like growth factor-I (IGF-I) may fan the flames of cancer, while too little of the protein may cause short stature, dementia and osteoporosis. New research investigates how the growth hormone/IGF system is affected by the important tumor suppressor gene p53. This interplay of two signaling pathways reinforces questions about the long-term risks of prescribing growth hormone, while suggesting a future new avenue for cancer therapy.